Login
Toggle navigation
Videos
Categories
Trending
Flash is missing. Download it from
Adobe
.
Sam Farres, M.D. Vascular Surgeon, Mayo Clinic
00:00:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
All About Thoracic Outlet Syndrome (TOS): Overview
Recent Videos
00:10:00
How LRT Capital's Lucas Krupinski Combines Economic Moats and Quant Discipline for Long-Term Outperformance|Mr. Tomicki,CEO,LRT Capital
00:10:00
AlphaBot Revolutionizes Alternative Investment Research with 10x Efficiency and Seamless Multi-Asset Integration at a Fraction of the Cost|Dmitri Alexeev,CIO,Man Group
00:10:00
Harcourt’s Strategy-Focused Fund of Hedge Funds Outperforms with Precision Manager Selection and Unmatched Fee Efficiency|Ilario Scasascia,ED,Vontobel Asset Management AG
00:10:00
Defying Convention with a Systematic Market Timing Strategy That Thrives in Volatility|Heeten H. Doshi,Founder,Doshi Capital
00:10:00
Exploiting market inefficiencies in undervalued and overlooked African markets|André Steyn,CEO,Steyn Capital
00:10:00
Europe’s Independent Hedge Fund Powerhouse with a Disciplined Edge and Global Reach|Dr Werner Goricki ,CIO,Prime Capital
00:10:00
A Quantitative Edge in China A-Shares and Global Access via Hong Kong|Bo Huang,President,Jasper Capital
00:10:00
Uncorrelated Returns, Predictable Yields: How Laureola’s Life Settlement Strategy Offers Stability and Alpha in Volatile Markets| Tony Bremness,CFA,Laureola Advisors
00:10:00
Why 2022 Marked the Greatest Asset Raising Environment in Hedge Fund History—and How Managers Can Win Big at Cap Intro Events|Don Steinbrugge,CEO,Agecroft Partners
00:10:00
John Katzman Urges EdTech Industry to Rethink Assumptions, Use Data for Support—Not Surveillance|John Katzman, Ceo, Noodle
00:10:00
Pioneering ESG-Driven Alpha Through Data, Discipline, and Sustainable Development Themes|Larry Abele ,CEO,Auriel Capital Management LLP
00:10:00
Mastering Volatility and Skew to Deliver Rare Alpha in Crowded, Convex Markets|Nigol Koulajian,CIO,AlphaQuest
00:10:00
Blending Quantitative Precision and Trading Experience to Navigate Japan’s Markets with Systematic Edge|Aman Oberoi,CEO,K2Q Capital
00:10:00
Contrarian UK Equity Specialists Unlocking Asymmetric Value in a Post-Brexit Market|Alyx Wood,CIO,Kernow Asset Management
00:10:00
Revolutionizing Art Investment Through Technology, Transparency, and Blue-Chip Access|Tony Dalwood,CEO,Gresham House Ventures
00:10:00
Empowering Global Investment Managers with Infrastructure, Compliance, and Expertise|Clayton Heijman,CEO,Privium Fund Management
Suggestions
00:10:00
AMC: Leading Independent Mining Consultancy for Global Success
00:10:00
Wahid Nawabi, AeroVironment CEO, discusses quarterly earnings, international demand, and technological innovation in defense on 'Closing Bell Overtime'.
00:10:00
We've built a team unified by one common goal|Will Robbins,partner,Contrary Capital
00:10:00
Brisanet CEO José Roberto Nogueira Talks Spectrum Needs and Market Rationalization for Growth | José Roberto Nogueira ,CEO, Brisanet Participações SA.
00:10:00
Emerald Resources' Oyadao Gold Project: Development Update and Investment Opportunity
00:10:00
James Clarke Reveals the Operators-First Philosophy Driving Clarke Capital Partners | James Clarke, Founder and CEO, Clarke Capital Partners
00:10:00
To build a fair and customer centric financial sector.|Emmalyn Shaw,Managing Partner,Flourish Ventures
00:10:00
AdTheorent is a programmatic digital advertising platform|CEO, AdTheorent Holding Company Inc
00:10:00
backing global entrepreneurs in the field of information technology|Eduardo Saverin,Co-Founder and Partner,B Capital Group
00:10:00
Stephen Tanda, CEO of Aptar, appeared on CNBC's 'The Exchange' to discuss the market outlook for pump and dispensing devices, as well as the company's focus on product innovation.
00:10:00
Strandline Resources: Emerging Mineral Sands Development and Strategic Expansion in Tanzania and Western Australia
00:10:00
We relentlessly pursue therapeutic options to reduce and treat infectious and inflammatory disease|Joe Todisco,Chief Executive Officer,CorMedix Inc